Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6.
Targeting the CACNA1A IRES as a Treatment for Spinocerebellar Ataxia Type 6. Cerebellum. 2018 02; 17(1):72-77.
View in:
PubMed
subject areas
Ajmaline
Animals
Calcium Channels
Calcium Channels, L-Type
Disease Models, Animal
Dose-Response Relationship, Drug
Gene Expression Regulation
HEK293 Cells
Humans
Inhibitory Concentration 50
Internal Ribosome Entry Sites
MicroRNAs
Mutation
Receptors, Atrial Natriuretic Factor
Spinocerebellar Ataxias
Transfection
Voltage-Gated Sodium Channel Blockers
authors with profiles
Xiaofei Du
Christopher M. Gomez